MiMedx Group, Inc. (MDXG)
4.54
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 12:02
MiMedx Group Net Income (TTM) : 6.239M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.239M |
| March 31, 2026 | 30.70M |
| December 31, 2025 | 48.58M |
| September 30, 2025 | 40.83M |
| June 30, 2025 | 31.96M |
| March 31, 2025 | 39.96M |
| December 31, 2024 | 42.00M |
| September 30, 2024 | 85.85M |
| June 30, 2024 | 86.81M |
| March 31, 2024 | 78.44M |
| December 31, 2023 | 67.44M |
| September 30, 2023 | 15.74M |
| June 30, 2023 | -1.531M |
| March 31, 2023 | -21.65M |
| December 31, 2022 | -30.20M |
| September 30, 2022 | -27.57M |
| June 30, 2022 | -21.48M |
| March 31, 2022 | -12.39M |
| December 31, 2021 | -10.28M |
| September 30, 2021 | -29.08M |
| June 30, 2021 | -46.16M |
| March 31, 2021 | -52.84M |
| December 31, 2020 | -49.28M |
| September 30, 2020 | -40.18M |
| June 30, 2020 | -8.384M |
| Date | Value |
|---|---|
| March 31, 2020 | -17.13M |
| December 31, 2019 | -25.58M |
| September 30, 2019 | -54.33M |
| June 30, 2019 | -66.88M |
| March 31, 2019 | -47.87M |
| December 31, 2018 | -29.98M |
| September 30, 2018 | 41.12M |
| June 30, 2018 | 58.75M |
| March 31, 2018 | 65.02M |
| December 31, 2017 | 64.73M |
| September 30, 2017 | 35.33M |
| June 30, 2017 | 21.20M |
| March 31, 2017 | 15.10M |
| December 31, 2016 | 11.97M |
| September 30, 2016 | 19.87M |
| June 30, 2016 | 23.10M |
| March 31, 2016 | 26.56M |
| December 31, 2015 | 29.45M |
| September 30, 2015 | 19.90M |
| June 30, 2015 | 17.05M |
| March 31, 2015 | 11.23M |
| December 31, 2014 | 6.22M |
| September 30, 2014 | 0.9605M |
| June 30, 2014 | -3.046M |
| March 31, 2014 | -3.414M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Anika Therapeutics, Inc. | -3.121M |
| Perspective Therapeutics, Inc. | -116.63M |
| ABVC BioPharma, Inc. | -7.600M |
| Enovis Corp. | -1.099B |
| Edwards Lifesciences Corp. | 978.60M |